I. Infectious Diseases Core Brief Abstract: The Infectious Diseases Core will serve as a resource regarding clinical infectious disease issues, providing consultation and training for CDUHR and other NDRI investigators. While the focus of this Core will be on infectious diseases related to drug use and HIV, Dr. Perlman (with input from consultants and clinical medicine experts invited for visits to CDUHR) will also provide training and consultation regarding other biomedical issues critical for developing an enhanced interdisciplinary (biomedical and socio-behavioral) understanding of HIV and related infections in drug users and their networks. Dr. Des Jarlais will facilitate international research on HIV and related infections in drug users. Bi-directional training, involving the CDUHR socio-behavioral investigators and clinical ID investigators from our affiliated medical institutions in New York, will be undertaken to support and encourage this interdisciplinary research agenda.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA011041-15
Application #
8375088
Study Section
Special Emphasis Panel (ZDA1-RXL-E)
Project Start
Project End
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
15
Fiscal Year
2012
Total Cost
$113,974
Indirect Cost
$25,772
Name
New York University
Department
Type
DUNS #
041968306
City
New York
State
NY
Country
United States
Zip Code
10012
Palamar, Joseph J; Acosta, Patricia; Ompad, Danielle C et al. (2018) A Qualitative Investigation Comparing Psychosocial and Physical Sexual Experiences Related to Alcohol and Marijuana Use among Adults. Arch Sex Behav 47:757-770
Paraskevis, Dimitrios; Nikolopoulos, Georgios K; Sypsa, Vana et al. (2018) Molecular investigation of HIV-1 cross-group transmissions during an outbreak among people who inject drugs (2011-2014) in Athens, Greece. Infect Genet Evol 62:11-16
Tempalski, Barbara; Cleland, Charles M; Williams, Leslie D et al. (2018) Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007. Subst Abuse Treat Prev Policy 13:28
Behrends, Czarina N; Nugent, Ann V; Des Jarlais, Don C et al. (2018) Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States. J Acquir Immune Defic Syndr 79:e76-e78
Duncan, Dustin T; Chaix, Basile; Regan, Seann D et al. (2018) Collecting Mobility Data with GPS Methods to Understand the HIV Environmental Riskscape Among Young Black Men Who Have Sex with Men: A Multi-city Feasibility Study in the Deep South. AIDS Behav 22:3057-3070
Perlman, David C; Jordan, Ashly E (2018) The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions. Curr HIV/AIDS Rep 15:96-112
Vasylyeva, Tetyana I; Liulchuk, Mariia; Friedman, Samuel R et al. (2018) Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine. Proc Natl Acad Sci U S A 115:1051-1056
Wolfson-Stofko, Brett; Elliott, Luther; Bennett, Alex S et al. (2018) Perspectives on supervised injection facilities among service industry employees in New York City: A qualitative exploration. Int J Drug Policy 62:67-73
Palamar, Joseph J (2018) What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA. J Psychoactive Drugs 50:88-93
Wolfson-Stofko, Brett; Gwadz, Marya V; Elliott, Luther et al. (2018) ""Feeling confident and equipped"": Evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in New York City. Drug Alcohol Depend 192:362-370

Showing the most recent 10 out of 339 publications